Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John W. Pearson is active.

Publication


Featured researches published by John W. Pearson.


Cancer Research | 1992

Preclinical Evaluation of Bryostatin as an Anticancer Agent against Several Murine Tumor Cell Lines: In Vitro versus in Vivo Activity

Ronald L. Hornung; John W. Pearson; Margaret Beckwith; Dan L. Longo


Journal of the National Cancer Institute | 1991

Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal Antibody

John W. Pearson; William E. Fogler; Kirk Volker; Noriko Usui; Sarah Goldenberg; Eileen Gruys; Charles W. Riggs; Kristin L. Komschlies; Robert H. Wiltrout; Takashi Tsuruo; Ira Pastan; Michael M. Gottesman; Dan L. Longo


Journal of the National Cancer Institute | 1996

Enhancement of Vincristine Cytotoxicity in Drug-Resistant Cells by Simultaneous Treatment With Onconase, an Antitumor Ribonuclease

Susanna M. Rybak; John W. Pearson; William E. Fogler; Kirk Volker; Sally E. Spence; Dianne L. Newton; Stanislaw M. Mikulski; Wojciech Ardelt; Charles W. Riggs; Hsiang-Fu Kung; Dan L. Longo


Cancer Research | 1989

Enhanced Therapeutic Efficacy of an Immunotoxin in Combination with Chemotherapy against an Intraperitoneal Human Tumor Xenograft in Athymic Mice

John W. Pearson; Gowsala P. Sivam; Ron Manger; Robert H. Wiltrout; Alton C. Morgan; Dan L. Longo


Cancer Research | 1989

Chemoimmunotoxin Therapy against a Human Colon Tumor (HT-29) Xenografted into Nude Mice

John W. Pearson; David J. FitzGerald; Mark C. Willingham; Robert H. Wiltrout; Ira Pastan; Dan L. Longo


Cancer Research | 1990

Enhanced Therapeutic Efficacy against an Ovarian Tumor Xenograft of Immunotoxins Used in Conjunction with Recombinant α-Interferon

John W. Pearson; E. Hedrick; W. E. Fogler; R. L. Bull; D. K. Ferris; C. W. Riggs; Robert H. Wiltrout; G. Sivam; A. C. Morgan; E. Groves; Dan L. Longo


Journal of the National Cancer Institute | 1974

Combined Drug and Immunostimulation Therapy Against a Syngeneic Murine Leukemia

John W. Pearson; Michael A. Chirigos; Sotiros D. Chaparas; Neal A. Sher


Journal of the National Cancer Institute | 1995

Reversal of Multidrug Resistance in Human Colon Cancer Cells Expressing the Human MDR1 Gene by Liposomes in Combination With Monoclonal Antibody or Verapamil

Shifra Sela; Syed Rafat Husain; John W. Pearson; Dan L. Longo; Aquilur Rahman


Journal of the National Cancer Institute | 1995

Enhancement by Recombinant Human Interferon Alfa of the Reversal of Multidrug Resistance by MRK-16 Monoclonal Antibody

William E. Fogler; John W. Pearson; Kirk Volker; Keiko Ariyoshi; Hirotsugu Watabe; Charles W. Riggs; Robert H. Wiltrout; Dan L. Longo


Journal of the National Cancer Institute | 1977

Effects of Depot Injections of Retinyl Palmitate on 7,12-Dimethylbenz[a]anthracene-induced Preneoplastic Changes in Rat Skin

Irene V. Brown; Bernard P. Lane; John W. Pearson

Collaboration


Dive into the John W. Pearson's collaboration.

Top Co-Authors

Avatar

Dan L. Longo

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Robert H. Wiltrout

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ira Pastan

Laboratory of Molecular Biology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David J. FitzGerald

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Dianne L. Newton

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

Gowsala P. Sivam

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Gowsala Sivam

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Kristin L. Komschlies

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge